Bioorganic & Medicinal Chemistry Letters 2008-07-01

Synthesis and biological activities of reveromycin A and spirofungin A derivatives.

Takeshi Shimizu, Takeo Usui, Makoto Fujikura, Makoto Kawatani, Tomoharu Satoh, Kiyotaka Machida, Naoki Kanoh, Je-Tae Woo, Hiroyuki Osada, Mikiko Sodeoka

Index: Bioorg. Med. Chem. Lett. 18(13) , 3756-60, (2008)

Full Text: HTML

Abstract

Various derivatives of reveromycin A, an inhibitor of eukaryotic cell growth, and spirofungin A, focusing on the 5S hydroxyl group and C18 hemisuccinyl group, were synthesized and their inhibitory effects on both the isoleucyl-tRNA synthetase activity and the survival of osteoclasts, and activities on the morphological reversion of src(ts)-NRK cells were examined. It was found that 2,3-dihydroreveromycin A is the promising derivative of reveromycin A based on the activity and stability.

Related Compounds

  • Reveromycin A

Related Articles:

Development and application of bioprobes for Mammalian cell cycle analyses.

2003-05-01

[Curr. Med. Chem. 10(9) , 727-32, (2003)]

Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases.

2009-11-01

[Cancer Sci. 100(11) , 1999-2005, (2009)]

Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.

2008-04-01

[J. Pharmacol. Sci. 106(4) , 547-54, (2008)]

Creation of novel reveromycin derivatives by alcohol-added fermentation.

2013-04-01

[J. Antibiot. 66(4) , 247-50, (2013)]

Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice.

2013-09-01

[Am. J. Orthod. Dentofacial Orthop. 144(3) , 368-80, (2013)]

More Articles...